Unknown

Dataset Information

0

XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa).


ABSTRACT: BACKGROUND:Exportin 1 (XPO1), also called chromosome region maintenance 1 (CRM1), is the sole exportin mediating transport of many multiple tumor suppressor proteins out of the nucleus. AIM AND METHODS:To verify the hypothesis that XPO1 inhibition affects prostate cancer (PCa) metastatic potential, orally available, potent and selective, SINE compounds, Selinexor (KPT- 330) and KPT-251, were tested in preclinical models known to generate bone lesions and systemic tumor spread. RESULTS:In vitro, Selinexor reduced both secretion of proteases and ability to migrate and invade of PCa cells. SINEs impaired secretion of pro-angiogenic and pro-osteolytic cytokines and reduced osteoclastogenesis in RAW264.7 cells. In the intra-prostatic growth model, Selinexor reduced DU145 tumor growth by 41% and 61% at the doses of 4 mg/Kg qd/5 days and 10 mg/Kg q2dx3 weeks, respectively, as well as the incidence of macroscopic visceral metastases. In a systemic metastasis model, following intracardiac injection of PCb2 cells, 80% (8/10) of controls, 10% (1/10) Selinexor- and 20% (2/10) KPT-251-treated animals developed radiographic evidence of lytic bone lesions. Similarly, after intra-tibial injection, the lytic areas were higher in controls than in Selinexor and KPT-251 groups. Analogously, the serum levels of osteoclast markers (mTRAP and type I collagen fragment, CTX), were significantly higher in controls than in Selinexor- and KPT-251-treated animals. Importantly, overall survival and disease-free survival were significantly higher in Selinexor- and KPT-251-treated animals when compared to controls. CONCLUSIONS:Selective blockade of XPO1-dependent nuclear export represents a completely novel approach for the treatment of advanced and metastatic PCa.

SUBMITTER: Gravina GL 

PROVIDER: S-EPMC4283114 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa).

Gravina Giovanni Luca GL   Tortoreto Monica M   Mancini Andrea A   Addis Alessandro A   Di Cesare Ernesto E   Lenzi Andrea A   Landesman Yosef Y   McCauley Dilara D   Kauffman Michael M   Shacham Sharon S   Zaffaroni Nadia N   Festuccia Claudio C  

Journal of hematology & oncology 20141005


<h4>Background</h4>Exportin 1 (XPO1), also called chromosome region maintenance 1 (CRM1), is the sole exportin mediating transport of many multiple tumor suppressor proteins out of the nucleus.<h4>Aim and methods</h4>To verify the hypothesis that XPO1 inhibition affects prostate cancer (PCa) metastatic potential, orally available, potent and selective, SINE compounds, Selinexor (KPT- 330) and KPT-251, were tested in preclinical models known to generate bone lesions and systemic tumor spread.<h4>  ...[more]

Similar Datasets

| S-EPMC4633607 | biostudies-literature
| S-EPMC3512237 | biostudies-literature
| S-EPMC3980736 | biostudies-literature
| S-EPMC4560410 | biostudies-literature
| S-EPMC2519715 | biostudies-literature
| S-EPMC3811176 | biostudies-literature
| S-EPMC6414360 | biostudies-literature
| S-EPMC4537003 | biostudies-literature
| S-EPMC3922416 | biostudies-literature
| S-EPMC4506247 | biostudies-literature